Racial Differences in the Association Between Adiposity Measures and the Risk of Hepatitis C-related Liver Disease

Overview

Journal J Clin Gastroenterol

Specialty Gastroenterology

Date 2012 Sep 8

PMID 22955261

Citations 1

Authors

Donna L White

Shahriar Tavakoli-Tabasi

Jill Kuzniarek

David J Ramsey

Hashem B El-Serag

Affiliations

Soon will be listed here.

Abstract

Background: African Americans have lower reported likelihood of hepatitis C virus-related cirrhosis than whites. It is unknown whether relative differences in the distribution of adipose tissue, lean mass, and other anthropometric measurements may explain these observed interethnic differences in disease risk.

Aim: : To evaluate the association between anthropometric measurements and advanced liver disease in a cross-sectional study of African American and white male veterans.

Methods: We used the validated FibroSURE-ActiTest to assess hepatic pathology, and direct segmental multichannel bioelectric impedance analysis for anthropometric measurements. Race-stratified logistic regression was employed to evaluate risk of high fibrosis progression rate (FPR) and advanced inflammation (A2 to A3).

Results: Among 330 eligible males (59% African American), there were 43 white and 57 African American males with high FPR, and 70 African American and 59 white with advanced inflammation. Percentage body fat (%BF) was a stronger predictor of high FPR risk than was a high body mass index in African Americans [odds ratio (OR)(adj)=2.08; 95% confidence interval (CI),0.83-5.23 for highest %BF vs. lowest tertile and OR(adj)=1.50; 95% CI,0.60-3.75 for obese vs. normal body mass index, respectively], but not in whites. Highest lean leg mass was associated with a nonsignificant increased risk of both high FPR and advanced inflammation in African Americans (OR(highFPRadj)=1.73; 95% CI, 0.73-4.10; OR(AdvancedinflammationAdj)=1.65; 95% CI, 0.76-3.56) versus a decreased risk of both in whites (OR(highFPRadj)=0.62; 95% CI, 0.21-1.79; OR(AdvancedinflammationAdj)=0.58; 95% CI, 0.22-1.48).

Conclusions: Interethnic differences in nontraditional anthropometric measurements like %BF suggests their potential role in understanding interethnic differences in hepatitis C virus-related liver disease risk in males.

Citing Articles

Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.

White D, Liu Y, Garcia J, El-Serag H, Jiao L, Tsavachidis S Int J Mol Epidemiol Genet. 2014; 5(3):164-76.

PMID: 25379136 PMC: 4214264.

References

Bonacini M, Groshen M, Yu M, Govindarajan S, Lindsay K . Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County. Am J Gastroenterol. 2001; 96(8):2438-41. DOI: 10.1111/j.1572-0241.2001.04050.x. View

Nevill A, Stewart A, Olds T, Holder R . Relationship between adiposity and body size reveals limitations of BMI. Am J Phys Anthropol. 2005; 129(1):151-6. DOI: 10.1002/ajpa.20262. View

Bini E, Brau N, Currie S, Shen H, Anand B, Hu K . Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol. 2005; 100(8):1772-9. DOI: 10.1111/j.1572-0241.2005.41860.x. View

Conjeevaram H, Kleiner D, Everhart J, Hoofnagle J, Zacks S, Afdhal N . Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology. 2006; 45(1):80-7. DOI: 10.1002/hep.21455. View

White D, Tavakoli-Tabasi S, Kuzniarek J, Pascua R, Ramsey D, El-Serag H . Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology. 2011; 55(3):759-68. PMC: 3399504. DOI: 10.1002/hep.24618. View

Thomas D, Thio C, Martin M, Qi Y, Ge D, OhUigin C . Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009; 461(7265):798-801. PMC: 3172006. DOI: 10.1038/nature08463. View

Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J . Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat. 2002; 9(2):128-33. DOI: 10.1046/j.1365-2893.2002.00341.x. View

Terrault N, Im K, Boylan R, Bacchetti P, Kleiner D, Fontana R . Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C. Clin Gastroenterol Hepatol. 2008; 6(12):1403-11. PMC: 3166617. DOI: 10.1016/j.cgh.2008.08.006. View

Alter M, Nainan O, McQuillan G, Gao F, Moyer L, Kaslow R . The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999; 341(8):556-62. DOI: 10.1056/NEJM199908193410802. View

10.

Ling C, de Craen A, Slagboom P, Gunn D, Stokkel M, Westendorp R . Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr. 2011; 30(5):610-5. DOI: 10.1016/j.clnu.2011.04.001. View

11.

Patel K, Benhamou Y, Yoshida E, Kaita K, Zeuzem S, Torbenson M . An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat. 2009; 16(3):178-86. DOI: 10.1111/j.1365-2893.2008.01062.x. View

12.

Wiley T, Brown J, Chan J . Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol. 2002; 97(3):700-6. DOI: 10.1111/j.1572-0241.2002.05555.x. View

13.

Liska D, Dufour S, Zern T, Taksali S, Cali A, Dziura J . Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents. PLoS One. 2007; 2(6):e569. PMC: 1892806. DOI: 10.1371/journal.pone.0000569. View

14.

Medici G, Mussi C, Fantuzzi A, Malavolti M, Albertazzi A, Bedogni G . Accuracy of eight-polar bioelectrical impedance analysis for the assessment of total and appendicular body composition in peritoneal dialysis patients. Eur J Clin Nutr. 2005; 59(8):932-7. DOI: 10.1038/sj.ejcn.1602165. View

15.

Kim H, Kim C, Kim D, Park M, Park H, Min S . External cross-validation of bioelectrical impedance analysis for the assessment of body composition in Korean adults. Nutr Res Pract. 2011; 5(3):246-52. PMC: 3133758. DOI: 10.4162/nrp.2011.5.3.246. View

16.

Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate M . IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009; 41(10):1100-4. DOI: 10.1038/ng.447. View

17.

Bacchetti P, Boylan R, Astemborski J, Shen H, Mehta S, Thomas D . Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis. PLoS One. 2011; 6(5):e20104. PMC: 3103523. DOI: 10.1371/journal.pone.0020104. View

18.

Poynard T, Bedossa P, Opolon P . Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997; 349(9055):825-32. DOI: 10.1016/s0140-6736(96)07642-8. View

19.

Leal A, Faintuch J, Morais A, Noe J, Bertollo D, Morais R . Bioimpedance analysis: should it be used in morbid obesity?. Am J Hum Biol. 2011; 23(3):420-2. DOI: 10.1002/ajhb.21143. View

20.

Satia-Abouta J, Galanko J, Potter J, Ammerman A, Martin C, Sandler R . Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol. 2003; 158(10):951-62. DOI: 10.1093/aje/kwg248. View